Solar urticaria: long-term rush hardening by inhibition spectrum narrow-band UVB 311nm

Wolf, Ronald; Herzinger, Thomas; Grahovac, Maja; Prinz, J. C.

doi:10.1111/ced.12048

Cited by 22 publications

(19 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…( n = 39), Wolf et al . ( n = 1), Collins and Ferguson ( n = 1)] . In an open trial using two protocols of NB‐UVB in patients both with UVB‐sensitive ( n = 29) and UVB‐insensitive SU ( n = 10), NB‐UVB was well tolerated; 20% of both groups reported SU relapse at 3 months.…”

Section: Psoralen–ultraviolet a For Specific Dermatosesmentioning

confidence: 99%

“…120 NB-UVB has also been reported to be helpful in SU 1)]. [121][122][123] In an open trial using two protocols of NB-UVB in patients both with UVB-sensitive (n = 29) and UVB-insensitive SU (n = 10), 121 NB-UVB was well tolerated; 20% of both groups reported SU relapse at 3 months. There are no comparative trials between NB-UVB and PUVA.…”

Section: Idiopathic Solar Urticariamentioning

confidence: 99%

See 1 more Smart Citation

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

et al. 2016

View full text Add to dashboard Cite

Section: Psoralen–ultraviolet a For Specific Dermatosesmentioning

confidence: 99%

Section: Idiopathic Solar Urticariamentioning

confidence: 99%

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

et al. 2016

View full text Add to dashboard Cite

“…Furthermore, it may be used in the prevention of polymorphic light eruption (photo hardening). Table lists additional indications .…”

Section: Uvb Phototherapymentioning

confidence: 99%

S1‐Guidelines on UV phototherapy and photochemotherapy

Herzinger

Berneburg

Ghoreschi

et al. 2016

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Known in part since antiquity, the salutary effects of sunlight again garnered increasing attention in the second half of the 19(th) century. The development of a device for ultraviolet irradiation of cutaneous tuberculosis by Finnsen at the onset of the twentieth century truly marked the beginning of modern phototherapy. In dermatology, treatment methods almost exclusively use wavelengths below the visible light range (ultraviolet light). Since the early 1970s, increasingly powerful artificial light sources have become available for UVB and UVA therapy as well as the combination of UVA and photosensitizers (photochemotherapy). High structural and procedural quality standards are an essential prerequisite for the implementation of effective as well as safe phototherapy. The following guidelines outline the current consensus of leading experts in the field of phototherapy with respect to indications, contraindications, and side effects of various treatment options available. Particular focus is also on adequate UV doses at the beginning and over the further course of treatment as well as on management of side effects.

show abstract

“…Sowohl bei der Behandlung der akuten und chronischen, steroidrefraktären kutanen Graft‐versus‐Host‐Erkrankung bei Erwachsenen und Kindern als auch zu deren Prophylaxe kann eine UV‐B‐Therapie erfolgen. In der Tabelle sind darüber hinaus weitere Indikationen genannt . Grundsätzlich können sowohl Breitband‐ als auch Schmalspektrum‐Strahler verwendet werden.…”

Section: Uv‐b‐phototherapieunclassified

S1‐Leitlinie zur UV‐Phototherapie und Photochemotherapie

Herzinger

Berneburg

Ghoreschi

et al. 2016

J Deutsche Derma Gesell

View full text Add to dashboard Cite

Die heilsame Wirkung des Sonnenlichts war teilweise schon im Altertum bekannt und fand in der zweiten Hälfte des 19. Jahrhunderts wieder zunehmend Beachtung. Den Beginn der modernen Phototherapien markiert die Entwicklung einer Apparatur zur ultravioletten Bestrahlung der Hauttuberkulose durch Finnsen zu Beginn des zwanzigsten Jahrhunderts. Zur Therapie von Hauterkrankungen finden beinahe ausschließlich die spektralen Bereiche unterhalb des sichtbaren Lichtes (ultraviolett) Anwendung. Seit den 1970er Jahren stehen zunehmend leistungsfähige künstliche Strahlenquellen bereit für die Therapie mit UVB, UVA und die Kombination von UVA mit Photosensibilisatoren (Photochemotherapie). Hohe strukturelle und prozedurale Qualitätsstandards sind unabdingbare Voraussetzung für die Durchführung einer gleichermaßen wirkungsvollen wie auch sicheren Phototherapie. Die Leitlinie formuliert den aktuellen Konsens führender Experten auf dem Gebiet der Phototherapie in Bezug auf die Indikationen für die jeweiligen Therapieverfahren, deren Gegenanzeigen und Nebenwirkungen und insbesondere für die Wahl der korrekten Dosis zu Beginn und im Verlauf einer Therapie sowie das Management von Nebenwirkungen.

show abstract

Solar urticaria: long-term rush hardening by inhibition spectrum narrow-band UVB 311nm

Cited by 22 publications

References 7 publications

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen–ultraviolet A therapy 2015

S1‐Guidelines on UV phototherapy and photochemotherapy

S1‐Leitlinie zur UV‐Phototherapie und Photochemotherapie

Contact Info

Product

Resources

About